[The effect of an alpha-glucosidase inhibitor on fatty liver in obesity].
Inui
Y
Y
Kawata
S
S
Kobatake
T
T
Tamura
S
S
Fujioka
S
S
Tokunaga
K
K
Minami
Y
Y
Matsuzawa
Y
Y
Tarui
S
S
D000284:Administration, Oral; D000818:Animals; D003511:Cyclohexanols / Q000008:administration & dosage / Q000494:pharmacology*; D005234:Fatty Liver / Q000378:metabolism* / Q000473:pathology; D065089:Glycoside Hydrolase Inhibitors; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D009765:Obesity / Q000378:metabolism*; D051381:Rats; D011924:Rats, Zucker
D003511:Cyclohexanols; D065089:Glycoside Hydrolase Inhibitors; C054577:AO 128